Ocular Therapeutix
OCUL
OCUL
168 hedge funds and large institutions have $1.22B invested in Ocular Therapeutix in 2024 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 42 increasing their positions, 49 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.07% more ownership
Funds ownership: 88.69% → 89.76% (+1.1%)
14% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 49
26% less call options, than puts
Call options by funds: $2.34M | Put options by funds: $3.17M
Holders
168
Holding in Top 10
10
Calls
$2.34M
Puts
$3.17M
Top Buyers
| 1 | +$24.6M | |
| 2 | +$9.19M | |
| 3 | +$8.7M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$6.17M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$5.74M |
Top Sellers
| 1 | -$14.4M | |
| 2 | -$13.8M | |
| 3 | -$5.79M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$4.98M |
| 5 |
SR
Summer Road
West Palm Beach,
Florida
|
-$4.24M |